1. Healthcare Ecosystem
Kenya Healthcare Ecosystem
- ✓Regulatory Excellence (PPB)
- ✓Private Healthcare Network
- ✓Regional Distribution Leadership
- ✓Local Pharmaceutical Manufacturing
- ✓Fertility Care Ecosystem

Healthcare & Pharmaceutical Market Intelligence
Kenya is East Africa's most organized pharmaceutical market, combining strong regulatory oversight, expanding private healthcare infrastructure, regional distribution leadership, and one of the region's most mature fertility care ecosystems.

56.4M
Population
USD 743M
Pharma Imports
70–75%
Import Dependency
USD 173M
Pharma Exports
77.2%
Female Factor Involvement
Kenya Healthcare Ecosystem

Key Market Indicators
USD 1.1–1.3B
Market Size
USD 350–500M
Dietary Supplements (9–12% CAGR)
USD 60–120M
Fertility Care Market
25–30%
Local Manufacturing

70–75% Imported Medicines

Among Evaluated Infertile Couples
77.2%
Female factor involvement (≈8 out of 10 cases)
51.9%
Male factor involvement (≈5 out of 10 cases)
41.8%
Female factor only
35.4%
Combined male & female factors
16.5%
Male factor only
Sources: Kenyatta National Hospital Study • 2025 Systematic Review & Meta-analysis (≈17% infertility prevalence, Sub-Saharan Africa) • WHO • OEC HS30 • World Bank • PPB Kenya • IQVIA
Large Opportunity Across

PCOS support

Preconception care

Male fertility support

Fertility nutraceuticals

Diagnostics & hormonal testing

East Africa's most organized pharmaceutical market

13–14M women of reproductive age (15–49 years)

USD 743M in pharmaceutical imports (2024)

≈95% of pharmaceutical APIs continue to be imported

One of East Africa's most developed fertility ecosystems